UK engineering firm, the adi Group, is continuing to strengthen its position in the marketplace with the launch of a new Life Sciences Division, it can be announced today.
The Group, which has a HQ in Birmingham and operates across 12 sites in the UK and Ireland, said the launch forms part of an exciting new phase in their ongoing development.
Via a new Manchester-based Division, from today the team at the adi Group will be working to directly support the requirements of the global life sciences industry.
The Division – based at Ashton Old Baths, Tameside, is made up of 13 people and two more will be joining in September.
Those spearheading the division’s output will be offering groundbreaking end-to-end project servicing capabilities which focus on the creation and management of sophisticated environments.
They will focus on delivering vital medical products that can be produced safely, compliantly, and sustainably.
The Division will utilise cutting-edge digital twin technology, where the team will essentially have a virtual representation of the client’s project. This will allow them to make concept changes within the virtual world before making a decision in real life.
The adi Group say this will not only mitigate risk, but also provide a shared collaborative environment with real-time yield data where all parties can view and assess progress.
This, in turn, will deliver clients with an opportunity to adjust parameters to meet the demands of the project as and when required.
Commenting on the launch of the new Division, Darren Lewis, who was recently appointed managing director and head of adi Life Sciences division, said: “I’m excited to be leading the new division, which is backed by an elite team of high-quality professionals. This is an exciting new branch to add to an already largely established engineering firm with various divisions across a wide range of major industries in the engineering and manufacturing sectors.
“It was an opportunity to bring a high-performing team of like minded people to an already established and successful business. The basis of adi Group has always been to provide a service with a multifaceted end-to-end approach, and we want to utilise those values for the new division to become a single point of responsibility for our clients.”
Mr Lewis, who has 30 years of experience in Pharma, said his aim is for the adi Group to be the “partner of choice” in the life sciences sector. He also wants to deliver sophisticated solutions via efficient and effective designs aligned with the requirements and end goal of the clients.
Paul Smith, Chief Operating Officer of the adi Group, added: “I’m thrilled to see a new team of progressive, technologically advanced experts within life sciences – the potential is enormous, bringing a service offering to the market that is entirely new and which conceptualizses the production of the life-saving medical products of tomorrow.”
The new division has been set up in Manchester-based offices that have been acquired to provide an innovative and modern space for the new team.
It becomes the second office in the North-West for adi Group, which is headquartered in the West-Midlands, but has primary hub offices across the UK and Ireland and project offices across a range of all the regions.
The adi Group has previous experience and partnerships working with 15 out of the top 20 pharmaceutical companies in the world , and has delivered a variety of projects across many years.
